At Ohio State’s Comprehensive Cancer Center – James Cancer Hospital and Solove Research Institute, there is much to be proud of. From news of our groundbreaking research that leads to new treatments for cancer to awards presented to our outstanding clinical staff, we hope you’ll join us in spreading the word of our great work and achievements:
- 25% or more patients who are diagnosed and treated at The James are on a clinical trial, compared to the 3-5% national average
- 14 years as a top-ranked cancer hospital by U.S.News & World Report
- 1 of 41 NCI Comprehensive Cancer Centers in the U.S.
- 1 of 7 cancer centers in nation funded by NCI to conduct phase I and phase II clinical trials
- 266,259 Outpatient Visits (An 11% increase over FY2011)
- 30,595 Radiation Treatments (A 21% increase over FY2011)
- 1,000,000 square feet in the New James Cancer Hospital and Solove Research Institute to open in 2014
- For 4 consecutive years (5 times in 6 years) The James has been named one of the nation’s safest and most effective hospitals by The Leapfrog Group. (We’re 1 of only 2 cancer hospitals in the nation to have been named by Leapfrog for 4 consecutive years.)
- 300 active clinical trials
- 228 adult cancer beds
- 111,364 number of cancer donors
- 227,670 total square feet of cancer program research space
- "Exceptional" NCI designation of The James
- 22 members of the National Comprehensive Cancer Network, of which the OSUCCC – James is a founding member
- 15th in the Nation for funding from the National Cancer Institute
- 93.3% inpatient satisfaction
- 94.9% overall patient satisfaction
- More than 300 researchers and 130 sub-specialized oncologists
- More than 400 Community Partners bring in significant support for cancer research and care
- More than 300 patients seen daily at the Stefanie Spielman Comprehensive Breast Center
- 11 or the 14 colleges at Ohio State have researchers working on cancer discoveries
- $109+ Million Total Cancer Research Funding at Ohio State
- $11+ Million has been raised for the Stefanie Spielman Fund for Breeast Cancer Research since its inception
- $42+ Million raised in 4 years for Pelotonia, benefiting cancer research at the OSUCCC – James